Asia Pacific Bone Cement Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type [Polymethyl Methacrylate Cement (PMMA), Calcium Phosphate Cement (CPC), Glass Polyalkenoate Cement (GPC), and Others], Application (Arthroplasty, Kyphoplasty,

Asia Pacific Bone Cement Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type [Polymethyl Methacrylate Cement (PMMA), Calcium Phosphate Cement (CPC), Glass Polyalkenoate Cement (GPC), and Others], Application (Arthroplasty, Kyphoplasty, and Vertebroplasty), and End User [Hospitals, Ambulatory Surgery Centers (ASCs), and Clinics]

The APAC bone cement market is expected to grow from US$ 200.02 million in 2021 to US$ 305.78 million by 2028; it is estimated to grow at a CAGR of 6.3% from 2021 to 2028.

The rising demand for kyphoplasty, arthroplasty, and vertebroplasty surgeries is expected to increase the sales of bone cement. Leading market players across the region are increasing their penetration across emerging markets by expanding their distribution networks and augmented manufacturing capabilities. Emerging markets across the region are expected to offer potential growth opportunities for key bone cement manufacturers in the years to come. This can be attributed to the rise in the aging population, high prevalence of osteoporosis, increased disposable income, improved healthcare infrastructure, and growth of medical tourism in several countries. Several emerging countries across the region have become business-friendly and adaptable hubs due to relatively less stringent regulations and data requirements. Most players are shifting their focus to emerging markets. High investments in life science and health research in emerging countries play a key role in upgrading the latest technologies in these countries. This factor, in turn, supports the inclination toward bone cement use, thereby driving the APAC market growth.

The COVID-19 pandemic significantly affected the clinical and surgical practice of orthopedic surgeons in the APAC region. Clinics were closed, or the practice hours were reduced. Similarly, surgical theaters were closed, reduced, or limited to semi-emergency and emergency surgeries. During their clinical practice, orthopedic surgeons were moderately concerned about contracting COVID-19 but were extremely concerned about transmitting this disease to their family members. The APAC countries, with their large and socioeconomically varied populations and infrastructures, were among the earliest to have to respond to the COVID-19 pandemic. Although the disease is not one of surgical trauma, its effects on orthopedic injuries have been notable. Medical systems had to adapt to better focus on patients with a highly communicable disease while providing essential services. Even though many countries saw a decrease in traumatic injuries during the initial periods, orthopedic trauma services nevertheless had to adapt to system-wide organizational changes. While each country took its individual approaches to address the pandemic, there were also consistencies in how musculoskeletal injuries and conditions were managed during these early stages of the pandemic. The pandemic affected three main aspects of the global economy – manufacturing, supply chain, and business and financial markets. Japan, China, South Korea, India, and Australia were the hardest-hit countries due to the rising number of COVID-19 cases and related deaths.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC bone cement market. The APAC bone cement market is expected to grow at a good CAGR during the forecast period.

APAC Bone Cement Market Revenue and Forecast to 2028 (US$ Million)

APAC Bone Cement Market Segmentation

APAC Bone Cement Market – by Type

Polymethyl Methacrylate Cement (PMMA)Calcium Phosphate Cement (CPC)Glass Polyalkenoate Cement (GPC)Others APAC Bone Cement Market – by Application

Arthroplasty Kyphoplasty Vertebroplasty APAC Bone Cement Market – by End User

Hospitals Ambulatory Surgery Centers (ASCs)Clinics APAC Bone Cement Market, by Country

Australia China India Japan South Korea Rest of APACAPAC Bone Cement Market - Companies Mentioned

Arthrex, Inc.Cardinal Health Inc.De Puy Synthes (The Orthopedics Company of Johnson & Johnson)DJO Global, Inc.Heraeus Holding Gmb HSmith & Nephew Stryker Corporation Tecres S.p.A.Teknimed Zimmer Biomet

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC bone cement market.        
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the APAC bone cement market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth market trends and outlook coupled with the factors driving the APAC bone cement market, as well as those hindering it  
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution